FFECX
Price
$14.45
Change
+$0.11 (+0.77%)
Updated
Jul 3 closing price
Net Assets
3.27B
VVIAX
Price
$70.10
Change
+$0.40 (+0.57%)
Updated
Jul 3 closing price
Net Assets
188.77B
Interact to see
Advertisement

FFECX vs VVIAX

Header iconFFECX vs VVIAX Comparison
Open Charts FFECX vs VVIAXBanner chart's image
Nuveen Dividend Value C
Price$14.45
Change+$0.11 (+0.77%)
VolumeN/A
Net Assets3.27B
Vanguard Value Index Adm
Price$70.10
Change+$0.40 (+0.57%)
VolumeN/A
Net Assets188.77B
FFECX vs VVIAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
FFECX vs. VVIAX commentary
Jul 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FFECX is a Buy and VVIAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VVIAX has more cash in the bank: 189B vs. FFECX (3.27B). VVIAX pays higher dividends than FFECX: VVIAX (2.18) vs FFECX (0.39). FFECX was incepted earlier than VVIAX: FFECX (26 years) vs VVIAX (25 years). FFECX (1.73) is less costly to investors than VVIAX (0.05). FFECX is a more actively managed with annual turnover of: 79.00 vs. VVIAX (9.00). FFECX (3000) and VVIAX (3000) have matching initial minimum investment requirements. VVIAX annual gain was more profitable for investors over the last year : 12.03 vs. FFECX (-0.74). VVIAX return over 5 years is better than : 80.13 vs. FFECX (35.94).
FFECXVVIAXFFECX / VVIAX
Total Expense Ratio1.700.053,400%
Annual Report Gross Expense Ratio1.730.053,460%
Fund Existence26 years25 years-
Gain YTD6.1586.19899%
Front LoadN/AN/A-
Min. Initial Investment30003000100%
Min. Initial Investment IRAN/AN/A-
Net Assets3.27B189B2%
Annual Yield % from dividends0.392.1818%
Returns for 1 year-0.7412.03-6%
Returns for 3 years12.8335.1736%
Returns for 5 years35.9480.1345%
Returns for 10 years-4.45115.67-4%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CAVA86.523.81
+4.61%
CAVA Group
ADTN9.560.16
+1.70%
ADTRAN Holdings
TWST38.170.49
+1.30%
Twist Bioscience Corp
ATMC11.84N/A
N/A
AlphaTime Acquisition Corp
SCNI2.20-0.07
-2.95%
Scinai Immunotherapeutics Ltd.